2011
DOI: 10.1016/j.cclet.2010.11.029
|View full text |Cite
|
Sign up to set email alerts
|

Design synthesis and biological evaluation of 3-substituted triazole derivatives

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3

Citation Types

0
4
0

Year Published

2012
2012
2023
2023

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 8 publications
(4 citation statements)
references
References 9 publications
0
4
0
Order By: Relevance
“…It is well known that triazoles are widely used in the development of agrochemicals and medicines based on their highly efficient and broad-spectrum biological activities. [8] But the drug resistance in the triazole structures has been significantly increased because of the frequent use of triazole drugs. [9] As a result, triazolium salts that bear similar chemical structures to triazoles have attracted considerable attention in recent years.…”
Section: Introductionmentioning
confidence: 99%
“…It is well known that triazoles are widely used in the development of agrochemicals and medicines based on their highly efficient and broad-spectrum biological activities. [8] But the drug resistance in the triazole structures has been significantly increased because of the frequent use of triazole drugs. [9] As a result, triazolium salts that bear similar chemical structures to triazoles have attracted considerable attention in recent years.…”
Section: Introductionmentioning
confidence: 99%
“…1-10d were synthesized by reacting the 1-10c with carbon disulphide in presence of KOH and conc sulfuric acid and then reacted with 3-bromo-1propyne to give the side chains 1-10e. The compounds 1-10 were carried out under the click-reaction 13,14 condition in the presence of CuSO 4 and sodium ascorbate. All the title compounds (1-10) described above were characterized by ESI and NMR spectroscopic analysis.…”
mentioning
confidence: 99%
“…We intended to alter the side chains to find potent systemic antifungal compounds with a broad antifungal spectrum and less potential to develop resistance. In our previous works [10][11][12][13][14][15][16], many studies on the structure-activity relationships (SAR) of antifungal azoles have been developed, and these studies have led to new compounds endowed with better biological and pharmacological properties.…”
Section: Introductionmentioning
confidence: 99%
“…The increasing frequency of fungal infections and development of resistance to the current treatment highlight the need for development of new triazole derivatives possessing broader antifungal spectra and higher therapeutic indexes. Azole antifungals act by competitive inhibition of CYP51, the enzyme that catalyzes the oxidative removal of the 14α-methyl group of lanosterol to give Δ 14,15 -desaturated intermediates in ergosterol biosynthesis [5]. In general, the active site of CYP51 for ligand binding can be divided into four subsites: a coordination bond with iron of the heme group, the hydrophilic H-bonding region, the hydrophobic region, and the narrow hydrophobic cleft formed by the residues in the helix B'-meander 1 loop and N-terminus of helix I [6].…”
Section: Introductionmentioning
confidence: 99%